LBF20303PG06: Difference between revisions

No edit summary
No edit summary
Line 6: Line 6:
|LipidBank=XPR1725
|LipidBank=XPR1725
|LipidMaps=LMFA03010045
|LipidMaps=LMFA03010045
|SysName=6,9alpha-Epoxy-11alpha,15S-dihydroxy-prosta-5Z,13E,17Z-trien-1-oic acid
|SysName=(6,9alpha) -Epoxy- (11alpha,15S) -dihydroxy-prosta- (5-cis,13-trans,17-cis) -trien-1-oic acid
|Common Name=&&Prostaglandin I_3&&
|Common Name=&&Prostaglandin I_3&&(6,9alpha) -Epoxy- (11alpha,15S) -dihydroxy-prosta- (5Z,13E,17Z) -trien-1-oic acid&&
|Source=PGI3 is synthesized from EPA by cyclooxygenase and PGI synthase.
|Source=PGI3 is synthesized from EPA by cyclooxygenase and PGI synthase.
|Chemical Synthesis=
|Chemical Synthesis=

Revision as of 07:35, 27 May 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



Prostaglandin I3
LBF20303PG06.png
Structural Information
(6,9α) -Epoxy- (11α,15S) -dihydroxy-prosta- (5-cis,13-trans,17-cis) -trien-1-oic acid
  • Prostaglandin I3
  • (6,9α) -Epoxy- (11α,15S) -dihydroxy-prosta- (5Z,13E,17Z) -trien-1-oic acid
Formula C20H30O5
Exact Mass 350.20932407
Average Mass 350.4492
SMILES C(=CC[C@@H](O)C=C[C@H]([C@H]12)[C@H](O)C[C@H](O[C@@H](C2)C=CCCC(O)=O)1)CC
Physicochemical Information
PGI3 is synthesized from EPA by cyclooxygenase and PGI synthase.
PGI3 has equal ability to PGI2 in inhibitting human platelet aggregation. Mann_NJ et al.
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20303PG06 See above. Mann_NJ et al. 1994